Viewing Study NCT03880695


Ignite Creation Date: 2025-12-24 @ 2:17 PM
Ignite Modification Date: 2026-01-27 @ 4:22 AM
Study NCT ID: NCT03880695
Status: UNKNOWN
Last Update Posted: 2019-03-21
First Post: 2019-03-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue Sarcoma
Sponsor: Peking University People's Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sarcoma View
Keywords: